Dudediligence.

Indaptus Therapeutics, Inc

INDPNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$3.1MSep ’24−$4.1MDec ’24−$4.5MMar ’25−$5.2MJun ’25−$3.0MSep ’25−$8.1MDec ’25−$2.5MMar ’26−$1.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$7.7M−$14.9M−$16.4M−$15.4M−$19.8M
Net income−$7.7M−$14.3M−$15.4M−$15.0M−$20.8M
Operating cash flow−$11.3M−$13.1M−$13.4M−$12.3M−$14.8M
Free cash flow−$11.3Mnone on filenone on filenone on filenone on file
Cash$39.1M$9.6M$13.4M$5.8M$8.5M
Shares outstanding8.3M8.4M8.4M428.8K2.2M